The biotech firmed up the details of its upcoming secondary share issue. However, the flotation will be dilutive to existing shareholders.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results